| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 15.3× | 26.5× | |
| Price / Book | 1.4× | 3.9× | |
| Price / Sales | 1.4× | 2.6× | |
| Price / Free cash flow | 645.6× | −8.9× | |
| EV / EBITDA | 12.8× | 17.1× | |
| Earnings yield | 6.6% | 2.1% | |
| Free cash flow yield | 0.2% | −3.5% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LENSE:LENSKARTLenskart Solutions Ltd · 🇮🇳 NSE | ₹639.95 | −1.01% | $11.69B | 225.2× | 5.6% | — |
RUNSE:RUBICONRubicon Research Ltd · 🇮🇳 NSE | ₹1,486.70 | −1.45% | $2.59B | 99.9× | 19.1% | — |
MONSE:MOLBIOMolbio Diagnostics Limited · 🇮🇳 NSE | ₹1,434.80 | −8.87% | $1.75B | 114.4× | 15.0% | — |
CONSE:CORONACorona Remedies Ltd · 🇮🇳 NSE | ₹2,010.00 | +0.30% | $1.29B | 66.5× | 24.8% | — |
SYNSE:SYMBIOTECSymbiotec Pharmalab Limited · 🇮🇳 NSE | ₹1,238.60 | −3.20% | $835.61M | 82.1× |
| 11.9% |
| — |
KPNSE:KPLKwality Pharmaceuticals Ltd · 🇮🇳 NSE | ₹3,366.00 | −1.08% | $366.42M | 51.7× | 20.3% | — |
SHNSE:SHUKRAPHARShukra Pharmaceuticals Ltd. · 🇮🇳 NSE | ₹68.62 | −0.38% | $317.6M | 136.9× | 24.5% | — |
FRNSE:FREDUNFredun Pharmaceuticals Ltd. · 🇮🇳 NSE | ₹1,438.40 | −2.66% | $248.81M | 72.5× | 11.7% | — |
SANSE:SAIPARENTSai Parenteral's Ltd · 🇮🇳 NSE | ₹483.00 | −0.88% | $224.49M | 149.6× | 2.9% | — |
BENSE:BETABeta Drugs Ltd · 🇮🇳 NSE | ₹1,719.60 | −3.56% | $200.56M | 46.0× | 16.9% | −5.3% |
